Physician profile
Christopher Scott
NPI 1225026693
$926.75
in general payments reported to CMS, 2019-2025
5 companies · $125 in 2025
The $125 reported for 2025 was more than what a typical Emergency Medical Services provider received nationally (typical 2025 total: $70.35).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $259 · 2020: $99.28 · 2022: $278 · 2023: $165 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $290.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $289.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $333.29 | 2019-2023 | Xarelto |
| Fisher & Paykel Healthcare INC | $313.68 | 2022-2023 | Fisher & Paykel Healthcare |
| Inari Medical, INC. | $135.93 | 2019 | |
| Roche Diagnostics Corporation | $124.71 | 2025 | Cobas Influenza A/B Nucleic Acid Test For Use On The Cobas Liat System |
| Alexion Pharmaceuticals, INC. | $19.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.